Amplifi Vascular Achieves Major Milestones with Positive Study Results, Funding, and FDA Approval

St. Louis-based company, Amplifi Vascular, has achieved significant milestones with positive first-in-human study results, a $6.9 million Series A financing round, and FDA approval of its Investigational Device Exemption (IDE).

=